Park Ha Biological Technology is trading at $2.41, up 6.17% on October 2, 2026, with broad risk-on sentiment a plausible contributor.

  • No company-specific announcement explaining the move surfaced in available coverage; company-specific trading volume data was unavailable.
  • The S&P 500 rose 1.08%, Nasdaq Composite 1.76%, and Dow 0.60%.
  • Gains followed weaker-than-expected September payroll growth and easing rate-hike expectations.